FR2271825B1 - - Google Patents

Info

Publication number
FR2271825B1
FR2271825B1 FR7516235A FR7516235A FR2271825B1 FR 2271825 B1 FR2271825 B1 FR 2271825B1 FR 7516235 A FR7516235 A FR 7516235A FR 7516235 A FR7516235 A FR 7516235A FR 2271825 B1 FR2271825 B1 FR 2271825B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7516235A
Other versions
FR2271825A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2271825A1 publication Critical patent/FR2271825A1/fr
Application granted granted Critical
Publication of FR2271825B1 publication Critical patent/FR2271825B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7516235A 1974-05-24 1975-05-23 Expired FR2271825B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/473,013 US3956302A (en) 1974-05-24 1974-05-24 Substituted pyrimidines

Publications (2)

Publication Number Publication Date
FR2271825A1 FR2271825A1 (fr) 1975-12-19
FR2271825B1 true FR2271825B1 (fr) 1981-12-04

Family

ID=23877827

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7516235A Expired FR2271825B1 (fr) 1974-05-24 1975-05-23

Country Status (9)

Country Link
US (1) US3956302A (fr)
JP (1) JPS511484A (fr)
BE (1) BE829417A (fr)
CA (1) CA1031777A (fr)
CH (1) CH610309A5 (fr)
DE (1) DE2522090A1 (fr)
FR (1) FR2271825B1 (fr)
NL (1) NL7505879A (fr)
ZA (1) ZA752761B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002951A (en) * 1979-03-19 1991-03-26 The Upjohn Company Method for treating bacterial and protozoal infections
US5434157A (en) * 1979-03-19 1995-07-18 The Upjohn Company 6-aryl pyrimidine compounds and method for treating viral infections and inducing interferon production
US4507302A (en) * 1979-03-19 1985-03-26 The Upjohn Company Method for treating arthritis with 6-aryl pyrimidine compounds
US5554617A (en) * 1979-09-28 1996-09-10 The Upjohn Company Method for treating cancer with 6-aryl pyrimidine compounds
US4460589A (en) * 1980-10-03 1984-07-17 The Upjohn Company Process for treating hypertension
US4308272A (en) * 1980-10-03 1981-12-29 The Upjohn Company Process for treating hypertension
US4593096A (en) * 1982-06-09 1986-06-03 The Upjohn Company Novel compounds and process for treating hypertension
EP0111440A1 (fr) * 1982-10-15 1984-06-20 Ciba-Geigy Ag Amino-2-pyrimidines, leur préparation et leur utilisation
IT1305313B1 (it) * 1998-07-17 2001-05-04 Colla Paolo 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1.
WO2002040021A2 (fr) * 2000-11-17 2002-05-23 Idenix (Cayman) Limited Procedes d'inhibition de la transmission du vih au moyen de 6-benzyl-4-oxopyrimidines substituees a application topique
DE602005018840D1 (de) 2005-04-14 2010-02-25 Applied Biosystems Llc 3'-modifizierte oligonukleotide mit pseudoisocytosin-nukleobasenderivaten sowie deren anwendungen als primer oder sonden
CN114644594B (zh) * 2022-03-24 2024-06-11 郑州猫眼农业科技有限公司 5-溴-2-氯嘧啶的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3554784A (en) 1967-06-05 1971-01-12 Procter & Gamble Softening of textile materials

Also Published As

Publication number Publication date
ZA752761B (en) 1976-04-28
CA1031777A (fr) 1978-05-23
US3956302A (en) 1976-05-11
CH610309A5 (fr) 1979-04-12
BE829417A (fr) 1975-11-24
JPS511484A (fr) 1976-01-08
FR2271825A1 (fr) 1975-12-19
DE2522090A1 (de) 1975-12-04
NL7505879A (nl) 1975-11-26

Similar Documents

Publication Publication Date Title
FR2262953B3 (fr)
FR2266712B3 (fr)
FR2269645A1 (fr)
FR2271825B1 (fr)
FR2313155B1 (fr)
FR2263797B1 (fr)
FR2292922B1 (fr)
FR2275685B1 (fr)
FR2295743B1 (fr)
JPS50102617A (fr)
FR2289420B1 (fr)
FR2272201A1 (fr)
FR2264228B1 (fr)
FR2280362B2 (fr)
FR2275549B1 (fr)
AU7891375A (fr)
AU485556B2 (fr)
AU465373B2 (fr)
FR2278477B1 (fr)
JPS50106168A (fr)
JPS50101835U (fr)
CH1283674A4 (fr)
BG23432A1 (fr)
DD109789A1 (fr)
CH822874A4 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse